The Association Between Existing Health Conditions and Adverse Events From Botulinum Toxins: Findings From a UK Cross-sectional Survey in 2024.

Aesthetic surgery journal 2026 Vol.46(5) p. 495-502

Ravindran R, Rahmati M, López-Gil JF, Yon DK, Pizzol D, Gawronska J, Richardson F, Keyes H, Barnett Y, Butler L, Smith L

관련 도메인

Abstract

[BACKGROUND] There is growing demand for Botulinum toxin (BoNT) injections in the UK. However, there is a scarcity of research in relation to associations between medical conditions and BoNT adverse events.

[OBJECTIVES] To investigate cross-sectional associations between existing medical conditions and the likelihood of adverse events in a large sample of UK BoNT users.

[METHODS] A cross-sectional observational survey on individuals' (≥18 years) experiences and adverse events with cosmetic BoNT injections. Data were collected on participants age, gender, existing health conditions, acute and long-term adverse events following BoNT treatment. To investigate the association between pre-existing physical conditions and the occurrence of post-BoNT adverse effects, multivariable logistic regression models were performed.

[RESULTS] Nine hundred and nineteen participants who received BoNT were included in the analysis. Multivariable logistic regression revealed that several pre-existing physical and psychiatric conditions were significantly associated with increased odds of specific post-BoNT adverse effects. Notably, individuals with skin disease (odds ratio [OR] 22.95, 95% confidence interval [CI] 2.64-132.03, P = .001), type 1 diabetes mellitus (OR 110.34, 95% CI 3.85-3381.06, P = .002), chronic migraine (OR 7.69, 95% CI 1.84-27.61, P = .003), and thyroid disorders (OR 6.18, 95% CI 1.27-23.44, P = .012) demonstrated significantly higher odds of developing nausea following BoNT administration. Multiple other significant associations were found between numerous existing health conditions and numerous adverse events.

[CONCLUSIONS] This study found that autoimmune, endocrine, neurological, and mental health comorbidities significantly increase the likelihood of adverse outcomes, ranging from bruising and ptosis to mood disturbance, neuromuscular weakness, and apparent treatment failure.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
해부 skin scispacy 1
해부 thyroid scispacy 1
해부 neuromuscular scispacy 1
약물 BoNT → Botulinum toxin C0006055
Botulinum Toxins
scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [OBJECTIVES] scispacy 1
약물 CI 3.85 scispacy 1
약물 CI 1.27-23.44 scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 cosmetic BoNT scispacy 1
질환 psychiatric C0033873
Psychiatry Specialty
scispacy 1
질환 skin disease C0037274
Dermatologic disorders
scispacy 1
질환 diabetes mellitus C0011849
Diabetes Mellitus
scispacy 1
질환 migraine C0149931
Migraine Disorders
scispacy 1
질환 thyroid disorders C0040128
Thyroid Diseases
scispacy 1
질환 nausea C0027497
Nausea
scispacy 1
질환 autoimmune, endocrine, neurological, and mental health comorbidities significantly increase the likelihood of adverse outcomes, ranging from bruising scispacy 1
질환 ptosis to mood disturbance scispacy 1
질환 neuromuscular weakness scispacy 1
기타 Botulinum Toxins scispacy 1
기타 BoNT → Botulinum toxin scispacy 1
기타 UK BoNT scispacy 1
기타 participants scispacy 1

MeSH Terms

Humans; Cross-Sectional Studies; Male; Female; United Kingdom; Middle Aged; Adult; Cosmetic Techniques; Botulinum Toxins; Young Adult; Aged; Neuromuscular Agents; Adolescent

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문